ARCHIVES

FDA Approives Lilly’s Alimta For 1st-Line Metastatic NSCLC

This article is from The Cancer Letter archive.

Vol. 31 No. 9 | September 26, 2008

Download PDF Visit The Full Archive

Related Articles

New SEER RFP Sees cheaper Way To Get Data

July 29, 1977

In Brief: LEO Sachs To Receive 1983 Bristol-Myers Award; 50 Percent Current Rate Achievable Now: Tylor

April 1, 1983

ASCO to Present 2013 Special Awards at Annual Meeting

May 31, 2013

NeoPharm To Begin Phase III Trial For Glioblastoma

December 26, 2003

IL-2 Trials Proliferate; Biotherapeutics Sees NCI Proposal As Vindication Of Its Policies

May 8, 1987

NCI contract Award

August 1, 1997